Grufity logoGrufity logo

Petmed Express Inc Stock Research

PETS

15.91USD-0.65(-3.93%)Market Closed

Market Summary

USD15.91-0.65
Market Closed
-3.93%

PETS Alerts

PETS Stock Price

PETS RSI Chart

PETS Valuation

Market Cap

335.3M

Price/Earnings (Trailing)

29.41

Price/Sales (Trailing)

1.29

EV/EBITDA

12.74

Price/Free Cashflow

14.59

PETS Price/Sales (Trailing)

PETS Profitability

EBT Margin

5.78%

Return on Equity

8.53%

Return on Assets

6.9%

Free Cashflow Yield

6.85%

PETS Fundamentals

PETS Revenue

Revenue (TTM)

260.5M

Revenue Y/Y

-3.04%

Revenue Q/Q

-9.98%

PETS Earnings

Earnings (TTM)

11.4M

Earnings Y/Y

-100.45%

Earnings Q/Q

-100.74%

Price Action

52 Week Range

15.8928.25
(Low)(High)

Last 7 days

-9.5%

Last 30 days

-15.7%

Last 90 days

-8.6%

Trailing 12 Months

-37.0%

PETS Financial Health

Current Ratio

4.31

PETS Investor Care

Dividend Yield

7.54%

Dividend/Share (TTM)

1.2

Shares Dilution (1Y)

4.30%

Diluted EPS (TTM)

0.57

Peers (Alternatives to Petmed Express)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.0T
514.0B
2.44% -40.04%
-368.89
1.95
9.40% -108.16%
23.0B
9.8B
-10.85% -25.12%
-18.09
2.34
-6.00% -109.33%
14.5B
9.8B
-16.71% -26.82%
-709.89
1.49
14.45% -288.94%
13.1B
2.6B
-16.82% -24.20%
-18.89
5.11
11.73% -479.56%
MID-CAP
3.5B
12.2B
-31.26% -71.79%
-2.66
0.29
-10.87% -916.03%
SMALL-CAP
1.9B
1.1B
-1.22% -55.16%
32.79
1.75
23.56% -41.21%
865.3M
1.9B
-5.11% -60.51%
-24.56
0.45
-30.01% -109.05%
530.9M
1.8B
11.88% -50.14%
-1.79
0.29
-16.43% -882.41%
335.3M
260.5M
-15.68% -36.98%
29.41
1.29
-6.68% -47.81%
291.4M
1.6B
4.24% -53.05%
-137.32
0.18
-2.37% -104.59%
210.2M
682.3M
-1.64% -52.46%
17.29
0.31
-0.22% -64.32%
113.0M
603.5M
-15.94% -85.94%
-0.58
0.19
29.04% 16.80%
14.1M
453.2M
-38.97% -92.06%
-0.32
0.03
-5.99% -122.89%

Financials for Petmed Express

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-0.7%260262264273279
Gross Profit-3.3%73.0076.0076.0078.0079.00
Operating Expenses6.0%60.0057.0052.0052.0052.00
  S&GA Expenses8.0%39.0036.0032.0031.0030.00
EBITDA-21.8%18.0023.0028.0030.00-
EBITDA Margin-21.2%0.07*0.09*0.11*0.11*-
Earnings Before Taxes-26.1%15.0020.0025.0027.0028.00
EBT Margin-25.6%0.06*0.08*0.09*0.10*-
Net Income-27.3%11.0016.0019.0021.0022.00
Net Income Margin-26.8%0.04*0.06*0.07*0.08*-
Free Cahsflow18.4%23.0019.0023.0017.00-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-2.4%165169165176168
  Current Assets-3.0%134138134151143
    Cash Equivalents6.1%10297.00105111109
  Net PPE0.2%25.0025.0025.0024.0025.00
Liabilities1.4%32.0031.0025.0034.0028.00
  Current Liabilities1.7%31.0031.0024.0033.0026.00
Shareholder's Equity-3.3%134138140142141
  Retained Earnings-5.1%117123127130131
  Additional Paid-In Capital11.9%17.0015.0013.0012.0010.00
Accumulated Depreciation-12.00----
Shares Outstanding0%21.0021.0021.0021.0020.00
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations18.9%27.0023.0025.0018.0028.00
  Share Based Compensation5.4%6.006.005.005.004.00
Cashflow From Investing-8.6%-8.81-8.12-7.26-1.75-1.85
Cashflow From Financing-0.1%-24.46-24.43-24.41-24.38-23.97
  Dividend Payments0.1%24.0024.0024.0024.0024.00
  Buy Backs-0.00----

Risks for PETS

What is the probability of a big loss on PETS?

95.8%


Probability that Petmed Express stock will be more than 20% underwater in next one year

65.4%


Probability that Petmed Express stock will be more than 30% underwater in next one year.

24.2%


Probability that Petmed Express stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PETS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Petmed Express was unfortunately bought at previous high price.

Drawdowns

Returns for PETS

Cumulative Returns on PETS

6.3%


10-Year Cumulative Returns

3.1%


7-Year Cumulative Returns

-13.1%


5-Year Cumulative Returns

-12.8%


3-Year Cumulative Returns

What are the long-term rolling returns for PETS?

FIve years rolling returns for Petmed Express.

Annualized Returns

Which funds bought or sold PETS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-23
MetLife Investment Management, LLC
unchanged
-
-18,885
183,655
-%
2023-03-17
American Portfolios Advisors
unchanged
-
-13.00
644
-%
2023-03-06
Rockefeller Capital Management L.P.
added
1.35
-
1,000
-%
2023-03-01
Lakewood Asset Management LLC
new
-
69,000
69,000
0.06%
2023-02-24
NATIXIS
new
-
10,620
10,620
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-11,000
116,000
-%
2023-02-21
MACQUARIE GROUP LTD
sold off
-100
-14,000
-
-%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
unchanged
-
9.00
3,009
-%
2023-02-17
TRUIST FINANCIAL CORP
new
-
183,407
183,407
-%
2023-02-16
MAVERICK CAPITAL LTD
added
31.72
216,350
1,330,350
0.03%

1–10 of 48

Latest Funds Activity

Are funds buying PETS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own PETS
No. of Funds

Petmed Express News

Seeking Alpha

PetMed Express (PETS) presents at Sidoti Small-Cap Virtual ....

Seeking Alpha,
3 days ago

Simply Wall St

The Motley Fool

Digital Journal

The Motley Fool

Schedule 13G FIlings of Petmed Express

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
7.04%
1,483,238
SC 13G/A
Jan 26, 2023
proshare advisors llc
3.2%
649,277
SC 13G/A
Jan 23, 2023
blackrock inc.
16.5%
3,473,358
SC 13G/A
Jan 27, 2022
blackrock inc.
15.7%
3,290,803
SC 13G/A
Jan 26, 2022
blackrock inc.
15.7%
3,290,803
SC 13G
Feb 11, 2021
renaissance technologies llc
6.21%
1,258,073
SC 13G/A
Feb 10, 2021
vanguard group inc
7.74%
1,569,843
SC 13G/A
Jan 25, 2021
blackrock inc.
15.4%
3,131,671
SC 13G
Feb 13, 2020
renaissance technologies llc
8.02%
1,616,400
SC 13G/A
Feb 12, 2020
vanguard group inc
6.86%
1,384,273
SC 13G/A

PETS Fair Value

Petmed Express fair value in different scenarios

The table shows the Fair Value estimates for Petmed Express for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

7.25

-54.43%

9.90

-37.77%

11.68

-26.59%

17.62

10.75%

20.58

29.35%
Current Inflation

6.98

-56.13%

9.30

-41.55%

10.88

-31.62%

16.01

0.63%

18.55

16.59%
Very High Inflation

6.63

-58.33%

8.55

-46.26%

9.89

-37.84%

14.08

-11.50%

16.14

1.45%

Historical Petmed Express Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Petmed Express

View All Filings
Date Filed Form Type Document
Feb 09, 2023
SC 13G/A
Major Ownership Report
Feb 09, 2023
S-8
Employee Benefits Plan
Feb 08, 2023
8-K
Current Report
Feb 07, 2023
10-Q
Quarterly Report
Feb 06, 2023
8-K
Current Report
Jan 26, 2023
SC 13G/A
Major Ownership Report
Jan 23, 2023
SC 13G/A
Major Ownership Report
Jan 19, 2023
8-K
Current Report
Jan 17, 2023
8-K
Current Report

Latest Insider Trading transactions for PETS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-07-28
FULGONI GIAN
acquired
163,200
21.76
7,500
-
2022-07-28
Cobb Peter
acquired
163,200
21.76
7,500
-
2022-07-28
Campbell Leslie C.G.
acquired
163,200
21.76
7,500
-
2022-07-28
PURCEL DIANA G
acquired
163,200
21.76
7,500
-
2022-07-28
Watson Jodi
acquired
163,200
21.76
7,500
-
2022-01-11
Watson Jodi
acquired
63,000
25.2
2,500
-
2022-01-11
Campbell Leslie C.G.
acquired
63,000
25.2
2,500
-
2021-07-30
FULGONI GIAN
acquired
235,425
31.39
7,500
-
2021-07-30
KORN RONALD J
acquired
235,425
31.39
7,500
-
2021-07-30
Watson Jodi
acquired
235,425
31.39
7,500
-

1–10 of 50

Matthew N. Hulett
220
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Income Statement

2022-09-30
Condensed Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Sales$ 65,394$ 67,386$ 135,581$ 146,698
Cost of sales46,94348,21297,187105,744
Gross profit18,45119,17438,39440,954
Operating expenses:    
General and administrative10,7536,95820,10414,999
Advertising3,8793,43510,22811,108
Depreciation8586941,6111,341
Total operating expenses15,49011,08731,94327,448
Income from operations2,9618,0876,45113,506
Other income:    
Interest income, net38874505159
Other, net261170459454
Total other income649244964613
Income before provision for income taxes3,6108,3317,41514,119
Provision for income taxes1,0311,9822,0613,342
Net income$ 2,579$ 6,349$ 5,354$ 10,777
Net income per common share:    
Basic (in dollars per share)$ 0.13$ 0.31$ 0.26$ 0.53
Diluted (in dollars per share)$ 0.13$ 0.31$ 0.26$ 0.53
Weighted average number of common shares outstanding:    
Basic (in shares)20,26120,17820,23520,144
Diluted (in shares)20,34420,56820,31820,384
Cash dividends declared per common share (in dollars per share)$ 0.30$ 0.30$ 0.60$ 0.60

PETS Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Current assets:  
Cash and cash equivalents$ 96,546$ 111,080
Accounts receivable, less allowance for doubtful accounts of $32 and $39, respectively1,5901,913
Inventories - finished goods34,02232,455
Prepaid expenses and other current assets5,4634,866
Prepaid income taxes595681
Total current assets138,216150,995
Noncurrent assets:  
Property and equipment, net25,18924,464
Intangible and other assets5,860860
Total noncurrent assets31,04925,324
Total assets169,265176,319
Current liabilities:  
Accounts payable23,98027,500
Accrued expenses and other current liabilities6,5855,697
Total current liabilities30,56533,197
Deferred tax liabilities547936
Commitments and contingencies
Total liabilities31,11234,133
Shareholders' equity:  
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share99
Common stock, $.001 par value, 40,000 shares authorized; 21,077 and 20,979 shares issued and outstanding, respectively2121
Additional paid-in capital14,87711,660
Retained earnings123,246130,496
Total shareholders' equity138,153142,186
Total liabilities and shareholders' equity$ 169,265$ 176,319